Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (KDMF) for 1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 783Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Bioindustria L.I.M. Spa
    Italy
    		 Samoh Pharmaceutical Co., Ltd. 20210218-209-J-588 Indapamide 2021-02-18 Bioindustria LIMSpA Italy Via Giustizia 1-15064 FRESONARA(AL)-ITALY (Via De Ambrosiis 2-4-6-15067 NOVI LIGURE-Italy)
    28/09/2024 Servier
    France
    		 Youngjin Pharmaceutical Co., Ltd. 20210405-209-J-922(1) Indapamide 2021-05-18 ORIL Industry France 13, rue Auguste Desgenétais, BP 17, BOLBEC, 76210, France